Pharmaceuticals
Innovating to treat disease more effectively
Our global Pharmaceuticals portfolio includes more than 60 key marketed products, many of which are innovative leaders in their therapeutic areas. In 2010 we received a total of 13 major approvals and made 16 regulatory submissions in the United States, Europe and Japan.
Learn more about our Pharmaceuticals Division
Learn more about Novartis pharmaceuticals in your country:
Local websites
Key pharmaceutical products marketed by Novartis are listed below in alphabetical order:
